Abstract
Summary
The global Nucleic Acid Delivery System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid Delivery System players cover Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nucleic Acid Delivery System (NADS) refers to a range of technologies and methods that are used to deliver nucleic acids, such as DNA or RNA, into cells or tissues. In gene therapy and genetic engineering, NADS play a critical role in delivering therapeutic genes to target cells to treat genetic diseases, as well as in introducing new genetic traits into organisms for various purposes.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
LPI (LP Information)' newest research report, the “Nucleic Acid Delivery System Industry Forecast” looks at past sales and reviews total world Nucleic Acid Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Delivery System sales for 2023 through 2029. With Nucleic Acid Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Delivery System and breaks down the forecast by vector, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Segmentation by application
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
United States market for Nucleic Acid Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid Delivery System players cover Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nucleic Acid Delivery System (NADS) refers to a range of technologies and methods that are used to deliver nucleic acids, such as DNA or RNA, into cells or tissues. In gene therapy and genetic engineering, NADS play a critical role in delivering therapeutic genes to target cells to treat genetic diseases, as well as in introducing new genetic traits into organisms for various purposes.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
LPI (LP Information)' newest research report, the “Nucleic Acid Delivery System Industry Forecast” looks at past sales and reviews total world Nucleic Acid Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Delivery System sales for 2023 through 2029. With Nucleic Acid Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Delivery System and breaks down the forecast by vector, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Segmentation by application
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Delivery System Market Size 2018-2029
2.1.2 Nucleic Acid Delivery System Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nucleic Acid Delivery System Segment by Vector
2.2.1 Viral Vectors
2.2.2 Lipid-based Carriers
2.2.3 Protein-based Carriers
2.3 Nucleic Acid Delivery System Market Size by Vector
2.3.1 Nucleic Acid Delivery System Market Size CAGR by Vector (2018 VS 2022 VS 2029)
2.3.2 Global Nucleic Acid Delivery System Market Size Market Share by Vector (2018-2023)
2.4 Nucleic Acid Delivery System Segment by Application
2.4.1 Drug Development
2.4.2 Gene Therapy
2.4.3 Biopharmaceuticals
2.4.4 Scientific Research
2.4.5 Others
2.5 Nucleic Acid Delivery System Market Size by Application
2.5.1 Nucleic Acid Delivery System Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nucleic Acid Delivery System Market Size Market Share by Application (2018-2023)
3 Nucleic Acid Delivery System Market Size by Player
3.1 Nucleic Acid Delivery System Market Size Market Share by Players
3.1.1 Global Nucleic Acid Delivery System Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nucleic Acid Delivery System by Regions
4.1 Nucleic Acid Delivery System Market Size by Regions (2018-2023)
4.2 Americas Nucleic Acid Delivery System Market Size Growth (2018-2023)
4.3 APAC Nucleic Acid Delivery System Market Size Growth (2018-2023)
4.4 Europe Nucleic Acid Delivery System Market Size Growth (2018-2023)
4.5 Middle East & Africa Nucleic Acid Delivery System Market Size Growth (2018-2023)
5 Americas
5.1 Americas Nucleic Acid Delivery System Market Size by Country (2018-2023)
5.2 Americas Nucleic Acid Delivery System Market Size by Vector (2018-2023)
5.3 Americas Nucleic Acid Delivery System Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Delivery System Market Size by Region (2018-2023)
6.2 APAC Nucleic Acid Delivery System Market Size by Vector (2018-2023)
6.3 APAC Nucleic Acid Delivery System Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nucleic Acid Delivery System by Country (2018-2023)
7.2 Europe Nucleic Acid Delivery System Market Size by Vector (2018-2023)
7.3 Europe Nucleic Acid Delivery System Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nucleic Acid Delivery System by Region (2018-2023)
8.2 Middle East & Africa Nucleic Acid Delivery System Market Size by Vector (2018-2023)
8.3 Middle East & Africa Nucleic Acid Delivery System Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nucleic Acid Delivery System Market Forecast
10.1 Global Nucleic Acid Delivery System Forecast by Regions (2024-2029)
10.1.1 Global Nucleic Acid Delivery System Forecast by Regions (2024-2029)
10.1.2 Americas Nucleic Acid Delivery System Forecast
10.1.3 APAC Nucleic Acid Delivery System Forecast
10.1.4 Europe Nucleic Acid Delivery System Forecast
10.1.5 Middle East & Africa Nucleic Acid Delivery System Forecast
10.2 Americas Nucleic Acid Delivery System Forecast by Country (2024-2029)
10.2.1 United States Nucleic Acid Delivery System Market Forecast
10.2.2 Canada Nucleic Acid Delivery System Market Forecast
10.2.3 Mexico Nucleic Acid Delivery System Market Forecast
10.2.4 Brazil Nucleic Acid Delivery System Market Forecast
10.3 APAC Nucleic Acid Delivery System Forecast by Region (2024-2029)
10.3.1 China Nucleic Acid Delivery System Market Forecast
10.3.2 Japan Nucleic Acid Delivery System Market Forecast
10.3.3 Korea Nucleic Acid Delivery System Market Forecast
10.3.4 Southeast Asia Nucleic Acid Delivery System Market Forecast
10.3.5 India Nucleic Acid Delivery System Market Forecast
10.3.6 Australia Nucleic Acid Delivery System Market Forecast
10.4 Europe Nucleic Acid Delivery System Forecast by Country (2024-2029)
10.4.1 Germany Nucleic Acid Delivery System Market Forecast
10.4.2 France Nucleic Acid Delivery System Market Forecast
10.4.3 UK Nucleic Acid Delivery System Market Forecast
10.4.4 Italy Nucleic Acid Delivery System Market Forecast
10.4.5 Russia Nucleic Acid Delivery System Market Forecast
10.5 Middle East & Africa Nucleic Acid Delivery System Forecast by Region (2024-2029)
10.5.1 Egypt Nucleic Acid Delivery System Market Forecast
10.5.2 South Africa Nucleic Acid Delivery System Market Forecast
10.5.3 Israel Nucleic Acid Delivery System Market Forecast
10.5.4 Turkey Nucleic Acid Delivery System Market Forecast
10.5.5 GCC Countries Nucleic Acid Delivery System Market Forecast
10.6 Global Nucleic Acid Delivery System Forecast by Vector (2024-2029)
10.7 Global Nucleic Acid Delivery System Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Creative Biogene
11.1.1 Creative Biogene Company Information
11.1.2 Creative Biogene Nucleic Acid Delivery System Product Offered
11.1.3 Creative Biogene Nucleic Acid Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Creative Biogene Main Business Overview
11.1.5 Creative Biogene Latest Developments
11.2 Evonik Health Care
11.2.1 Evonik Health Care Company Information
11.2.2 Evonik Health Care Nucleic Acid Delivery System Product Offered
11.2.3 Evonik Health Care Nucleic Acid Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Evonik Health Care Main Business Overview
11.2.5 Evonik Health Care Latest Developments
11.3 Factor Bioscience
11.3.1 Factor Bioscience Company Information
11.3.2 Factor Bioscience Nucleic Acid Delivery System Product Offered
11.3.3 Factor Bioscience Nucleic Acid Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Factor Bioscience Main Business Overview
11.3.5 Factor Bioscience Latest Developments
11.4 Polyplus
11.4.1 Polyplus Company Information
11.4.2 Polyplus Nucleic Acid Delivery System Product Offered
11.4.3 Polyplus Nucleic Acid Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Polyplus Main Business Overview
11.4.5 Polyplus Latest Developments
11.5 AccuRna
11.5.1 AccuRna Company Information
11.5.2 AccuRna Nucleic Acid Delivery System Product Offered
11.5.3 AccuRna Nucleic Acid Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AccuRna Main Business Overview
11.5.5 AccuRna Latest Developments
12 Research Findings and Conclusion